Compound Detail
CHEMBL535650
MEFLOQUINE HYDROCHLORIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL535650 |
| Name | MEFLOQUINE HYDROCHLORIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WESWYMRNZNDGBX-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL416956 |
| Active Moiety | CHEMBL416956 |
4
Targets
18
Activities
2
Assay Types
0
PK Parameters
18
Publications
12
Known Names
3
Indications
1
Mechanisms
Molecular Properties
378.3
MW (Da)
4.45
ALogP
3
HBA
2
HBD
45.1
PSA (Ų)
0.76
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1989 |
| Availability | Prescription |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Ferriprotoporphyrin IX inhibitor | INHIBITOR | Ferriprotoporphyrin IX | ✓ | ✓ |
Indications
Malaria Malaria, Falciparum Malaria, Vivax
Drug Warnings
Black Box Warning
psychiatric toxicity
Activity Summary
IC50 17 meas. best 8.72
EC50 1 meas. best 5.12
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 8.72 | 8.208 | 1.9 | 10 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.25 | 5.25 | 5623.4 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.15 | 5.03 | 7110.0 | 3 |
| Unchecked CHEMBL612545 | EC50 | 5.12 | 5.12 | 7610.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.72 | 4.61 | 19150.0 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17220424 | 10.1128/aac.01313-06 | Plasmodium falciparum | 12 |
| 19164150 | 10.1128/aac.00241-08 | Plasmodium falciparum | 3 |
| 25801154 | 10.1016/j.bmc.2015.02.061 | Plasmodium falciparum | 3 |
| - | 10.1101/2020.03.25.008482 | SARS-CoV-2 | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 2 |
| - | 10.1101/2020.03.25.008482 | ADMET | 2 |
| - | 10.1101/2020.03.25.008482 | Vero C1008 | 2 |
| 26453006 | 10.1016/j.bmcl.2015.09.034 | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | 1 |
| 26453006 | 10.1016/j.bmcl.2015.09.034 | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 | 1 |
| 21995505 | 10.1021/np200429b | Plasmodium falciparum | 1 |
| 19186946 | 10.1021/jm801484v | Plasmodium berghei | 1 |
| - | 10.1101/2020.04.03.023846 | SARS-CoV-2 | 1 |
| 12873512 | 10.1016/s0960-894x(03)00492-x | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | Caco-2 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | ADMET | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| - | 10.1016/S0960-894X(00)80654-X | Mus musculus | 1 |
Data from ChEMBL 36 via Core Engine